BioMimetic Therapeutics, Inc.'s Clinical Investigator To Present Orthopedic Clinical Results From Canadian Trial On November 4

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Company plans to release on Monday, November 6, 2006 its financial results for the three and nine months ended September 30, 2006. The Company will host a conference call and audio webcast at 5:00 p.m. EST the same day. Dr. Samuel E. Lynch, president and CEO, and members of the Company’s management team will host the call to discuss the Company’s orthopedic product development programs and third quarter 2006 financial results.